ArticleFrontiers in surgery2025
Comparison of clinical efficacy of two approaches for endoscopic lumbar fusion surgery in the treatment of single-segment lumbar spondylolisthesis.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Lumbar Spondylolisthesis (LSP) is a frequently encountered degenerative disorder of the spine. Unilateral biportal endoscopy (UBE) and percutaneous endoscopy (PE) have each shown promising initial results in managing this condition. This study aimed to compare the clinical efficacy of unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) and percutaneous endoscopic lumbar interbody fusion (PE-LIF) in treating single-level LSP, with the objective of providing high-quality evidence to support clinical decision-making. Methods: A retrospective analysis was conducted on clinical records from 118 patients diagnosed with single-segment LSP who were treated at the Sixth Affiliated Hospital of Xinjiang Medical University between June 2021 and August 2023. Participants were categorized into two groups: UBE-LIF ( Results: All procedures were successfully completed. Intraoperative blood loss was slightly higher in the PE-LIF group, without significant difference ( Conclusions: Large randomized controlled trials are needed to robustly examine the comparative efficacy of these surgical options for lumbar spondylolisthesis. UBE-LIF appears advantageous in reducing operative time and improving surgical field exposure, which may potentially lower anesthesia-related risks and decrease anesthesia complications. Future large randomized controlled trials are needed to robustly examine the comparative efficacy of these techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.